James R. Sapirstein R.Ph., M.B.A. Net Worth

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Mr A AZRX stock SEC Form 4 insiders trading

Mr has made over 6 trades of the AzurRx BioPharma Inc stock since 2015, according to the Form 4 filled with the SEC. Most recently he exercised 16,666 units of AZRX stock worth $24,999 on 27 October 2016.

The largest trade he's ever made was exercising 16,666 units of AzurRx BioPharma Inc stock on 27 October 2016 worth over $24,999. On average, Mr trades about 1,633 units every 17 days since 2014. As of 27 October 2016 he still owns at least 29,666 units of AzurRx BioPharma Inc stock.

You can see the complete history of Mr Sapirstein stock trades at the bottom of the page.

Mr. James R. Sapirstein R.Ph., M.B.A. biography

James R. Sapirstein R.Ph., M.B.A. is the CEO, Pres & Non-Independent Director at AzurRx BioPharma Inc.

What is the salary of Mr A?

As the CEO and Pres & Non-Independent Director of AzurRx BioPharma Inc, the total compensation of Mr A at AzurRx BioPharma Inc is $622,005. There are no executives at AzurRx BioPharma Inc getting paid more.

How old is Mr A?

Mr A is 59, he's been the CEO and Pres & Non-Independent Director of AzurRx BioPharma Inc since . There are 5 older and 3 younger executives at AzurRx BioPharma Inc. The oldest executive at AzurRx BioPharma Inc is Vern Schramm, 78, who is the Independent Director.

What's Mr A's mailing address?

James's mailing address filed with the SEC is 126 Valley Rd C, Glen Rock, NJ 07452, USA.

Insiders trading at AzurRx BioPharma Inc

Over the last 8 years, insiders at AzurRx BioPharma Inc have traded over $510,400 worth of AzurRx BioPharma Inc stock and bought 335,700 units worth $727,436 . The most active insiders traders include Charles J Casamento, Edmund Burke Jr. Ross, and Partners Llcbalk Matthew Pe.... On average, AzurRx BioPharma Inc executives and independent directors trade stock every 82 days with the average trade being worth of $262,052. The most recent stock trade was executed by Johan M. Spoor on 28 December 2018, trading 38,583 units of AZRX stock currently worth $50,158.

What does AzurRx BioPharma Inc do?

AzurRx BioPharma Inc executives and stock owners

AzurRx BioPharma Inc executives and other stock owners filed with the SEC include:

• James R. Sapirstein R.Ph., M.B.A.,
  CEO, Pres & Non-Independent Director
• James Pennington,
  Chief Medical Officer
• James Sapirstein,
  President, Chief Executive Officer, Director
• Alastair Riddell,
  Independent Director
• Edward Borkowski,
  Independent Chairman of the Board
• Vern Schramm,
  Independent Director
• Charles Casamento,
  Independent Director
• Gregory Oakes,
  Independent Director
• Daniel Schneiderman,
  Chief Financial Officer
• Martin Krusin M.B.A.,
  Sr. VP of Corp. Devel.
• Johan M. Spoor,
  
• Partners Llcbalk Matthew Pe...,
  
• Edmund Burke Jr. Ross,
  
• Maged Shenouda,
  CHIEF FINANCIAL OFFICER
• Daniel Dupret,
  CHIEF SCIENTIFIC OFFICER
• Mary Theresa Coelho,